ArticleOncotarget2017

Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit.

Bo Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.